CaaMTech is a psychedelic drug research company that aims to develop novel tryptamines through fundamental scientific research.


“CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine. CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.”

Preventing bad trips is one of their stated goals (see the Vice article below). The focus here is on ‘aeruginascin’ which is one of the lesser known tryptamines in magic mushrooms.

Key Staff

  • Andrew Chadeayne – Founder & CEO
  • Davis Wuolle – Technology & Marketing
  • Jon Cooper – Board Member


Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account